Vireo Health International Inc., a multi-state cannabis company, said it has launched a new cannabis-based brand called ‘Midnight’.
The Midnight brand launched at Vireo’s four medical dispensaries in New York as a softgel product. It will also be available via wholesale channels to other licensed dispensaries in New York.
Minneapolis, Minnesota-based Vireo has active operations in exclusively medical-only markets and licenses in seven states as well as the Commonwealth of Puerto Rico.
According to Vireo, Midnight products are ideally formulated with a balanced blend of multiple cannabinoids, including tetrahydrocannabinol or THC, cannabidiol or CBD, and CBN.
CBD is a chemical in the marijuana plant often used for medicinal purposes, and does not have the intoxicating effects like those caused by or THC.
Preliminary research indicated that CBN, one of the first identified cannabinoids in 1896, may have beneficial properties as an anti-bacterial, anti-inflammatory, and appetite…
